8-KCorporate ChangesExhibits & Filings

Edwards Lifesciences Corp 8-K Report, Bylaw Amendment (Mar 2, 2016)

Filed March 2, 2016For Securities:EW

Summary

This 8-K filing from Edwards Lifesciences (EW) details amendments to its corporate bylaws, primarily focused on enhancing shareholder rights and governance. The most significant changes include the implementation of a "proxy access" provision, allowing qualifying shareholders to nominate director candidates to be included in the company's proxy materials. This is a notable shift towards greater shareholder influence in board composition. Additionally, the threshold for shareholders to call a special meeting has been lowered significantly, empowering a broader group of investors to convene for urgent matters. These amendments reflect a proactive approach by Edwards Lifesciences to align with evolving corporate governance best practices and shareholder expectations. While these changes do not directly impact the company's financial performance or product lines, they are important for investors to understand as they pertain to the long-term governance and potential for shareholder engagement. The proxy access and reduced special meeting threshold will be effective for the 2017 annual meeting and onwards, indicating a strategic move towards a more responsive governance structure.

Key Highlights

  • 1Edwards Lifesciences has amended its corporate bylaws, effective February 25, 2016.
  • 2Key amendment: Implementation of "proxy access," enabling certain long-term shareholders to nominate directors for inclusion in company proxy materials.
  • 3Proxy access requires a minimum 3% ownership stake held continuously for at least three years by a stockholder or a group of up to 30 stockholders.
  • 4Nominees under proxy access can constitute up to the greater of two individuals or 20% of the Board of Directors.
  • 5Significant reduction in the threshold for shareholders to call a special meeting, lowered from 25% to 15% of outstanding shares.
  • 6Updates made to director nomination and other business proposal windows for annual meetings, generally requiring notice 120-150 days prior.
  • 7These bylaw changes will first be applicable for the Company's 2017 annual meeting of stockholders.

Frequently Asked Questions

Proxy access is a corporate governance provision that allows eligible shareholders to nominate their own candidates for the Board of Directors, and have those candidates included in the company's official proxy materials. This empowers long-term shareholders by giving them a more direct say in board composition, potentially leading to greater accountability and alignment with shareholder interests.

To utilize proxy access, a shareholder (or a group of up to 30 shareholders) must have continuously owned at least 3% of the company's outstanding common stock for a minimum of three years. The shareholder(s) and their nominee(s) must also meet other specific requirements outlined in the amended bylaws.

The reduction of the ownership threshold required to call a special meeting from 25% to 15% of outstanding shares makes it easier for a larger group of shareholders to convene a special meeting. This enhances shareholder ability to address important and time-sensitive matters outside of the regular annual meeting schedule.

The amended bylaws, including the proxy access and reduced special meeting threshold, will first be applicable for the Company's 2017 annual meeting of stockholders.